4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation outcomes after nivolumab monotherapy for +relapsed/refractory hodgkin lymphoma (CheckMate 039 and CheckMate 205)
    Meeting Abstract

    Carlo-Stella, C.; Collins, G.; Armand, P.; Zinzani, P. L.; Cohen, J. B.; Halwani, A.; Millenson, M.; Provencio, M.; Domingo Domenech, E.; Giulino-Roth, L.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Overall survival with nivolumab (NIVO) and ipilimumab (IPI) combination therapy in a phase III trial of advanced melanoma (CHECKMATE 067)
    Meeting Abstract

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Keynote-045: Open-label, phase 3 study of pembrolizumab versus investigator's choice of paclitaxel, docetaxel, or vinflunine for previously treated advanced urothelial cancer
    Meeting Abstract

    Quinn, D.; Bellmunt, J.; de Wit, R.; Vaughn, D. J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Trial of rucaparib in prostate indications 2 (TRITON2): An international, multicentre, open-label phase 2 study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Shapiro, J.; Voskoboynik, M.; Krieger, L.; Byard, I.; Clay, T.; Ganju, V.; Abida, W.; Chowdhury, S.; Watkins, S.; Despain, D.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL) of pembrolizumab vs chemotherapy for previously treated advanced urothelial cancer (UC) in KEYNOTE-045
    Meeting Abstract

    Quinn, D.; Vaughn, D. J.; Bellmunt, J.; de Wit, R.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Hybrid-capture based comprehensive genomic profiling of hepatocellular carcinoma identifies patients who may benefit from targeted therapies and immune checkpoint blockade
    Meeting Abstract

    Suh, J.; Severson, E.; Hechtman, J.; Frampton, G.; Fabrizio, D.; Sun, J.; Ali, S.; Gu, P.; Klempner, S.; Miller, V.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • The Delphian node revisited: An uncommon site of recurrence
    Journal Article

    Dy, B. M.; Shaha, A. R.; Tuttle, R. M.
    Journal of the Endocrine Society (2017)

    Fulltext@MSK | Save
  • Effects of rapid weight loss on systemic and adipose tissue inflammation and metabolism in obese postmenopausal women
    Journal Article

    Alemán, J. O.; Iyengar, N. M.; Walker, J. M.; Milne, G. L.; Da Rosa, J. C.; Liang, Y.; Giri, D. D.; Zhou, X. K.; Pollak, M. N.; Hudis, C. A.; more...
    Journal of the Endocrine Society (2017)

    Fulltext@MSK | Save
  • 4th Symposium on Primary Breast Cancer in Older Women. Theme: Putting personalized care into practice (Held: 3 March 2017)
    Journal Article

    Cheung, K. L.; Morgan, D.; Brain, E.; Poortmans, P.; Parks, R.; Korc-Grodzicki, B.; Ugolini, F.; Shakir, T.; Tsang, J.; Stone, H.; more...
    Breast Cancer Management (2017)

    Fulltext@MSK | Save